SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001108205-22-000022
Filing Date
2022-11-09
Accepted
2022-11-09 16:02:07
Documents
14
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cris-20221109.htm   iXBRL 8-K 38562
2 EX-99.1 a3q22earningspressrelease.htm EX-99.1 89930
6 image_0a.jpg GRAPHIC 13933
  Complete submission text file 0001108205-22-000022.txt   300302

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20221109.xsd EX-101.SCH 1906
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20221109_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20221109_pre.xml EX-101.PRE 13052
8 EXTRACTED XBRL INSTANCE DOCUMENT cris-20221109_htm.xml XML 11905
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

IRS No.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 221372441
SIC: 2836 Biological Products, (No Diagnostic Substances)